Virta Health announced that real-world data for its diabetes reversal platform demonstrated narrowing gaps in care.
The company shared its data at the American Diabetes Association’s 83rd Scientific Sessions. The research highlighted its impact on health equity. It demonstrated significant health improvement and medication reduction for members in the most and least disadvantaged U.S. neighborhoods.
Virta said diabetes disproportionately affects racial and ethnic minorities and those living in low-income areas. Additionally, those with financial hardships prove more likely to receive prescriptions for diabetes drugs that are older and harder to manage due to affordability and access. With complex regimens, these lower-income patients have a higher likelihood of hospitalization and severe diabetes complications.
Get the full story at our sister site, Drug Delivery Business News.